|
V.SBM
|
Do I feel mislead over the years? Yes - after the departure of Neil Do I...
|
|
V.SBM
|
I support that. The bonuses for TFC-1067 shouldn't be necessary in the...
|
|
V.SBM
|
In light of the lame R+F financial terms, the bonuses are offensive to the...
|
|
V.SBM
|
I beg to somewhat differ - the initial decline from 56 cents was because of...
|
|
V.SBM
|
I just noticed that disussion with potential partners for TFC-1067 global...
|
|
V.SBM
|
Both human and vet in Phase I, that's my opinion. Howard has actually...
|
|
V.SBM
|
The expected Letters to shareholders is yet to be released. Previously they...
|
|
V.SBM
|
The volume was triggered by selling - there are always buyers waiting below. ...
|
|
V.SBM
|
They pushed the cancer antigen actively in the early days, seeking a partner....
|
|
V.SBM
|
I've been invested for years. Looking back I would have been better off...
|
|
V.SBM
|
I agree, enough is enough. Don't think CFO give away a cent... Should...
|
|
V.SBM
|
We can still enjoy the fulfillment of one or two milestones in May. In...
|
|
V.SBM
|
The overall trend of close this week points in the right direction. I've...
|
|
V.SBM
|
Only six weeks left to nail the milestones. I think the anti-aging clinical...
|
|
V.SBM
|
Board member Alex Marazzi has exercised 100 000 options. Filed April 12, 2021...
|
|
V.SBM
|
The higher concentration will require a prescription, hence the top-10 pharma...
|
|
V.SBM
|
The value of the compound as well as the scientific platform grows...
|
|
V.SBM
|
I'm not saying that I'm satisfied, but to be fair the market cap has...
|
|
V.SBM
|
Based on the NR's at least two batches of 20kg have been produced in...
|
|
V.SBM
|
Would be good to know how many tubes needed annually for the average user of...
|